These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31080871)

  • 1. Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies.
    Perani D; Iaccarino L; Jacobs AH;
    Alzheimers Dement (Amst); 2019 Dec; 11():327-332. PubMed ID: 31080871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies.
    Perani D; Iaccarino L; Lammertsma AA; Windhorst AD; Edison P; Boellaard R; Hansson O; Nordberg A; Jacobs AH;
    Alzheimers Dement; 2019 Aug; 15(8):1081-1103. PubMed ID: 31230910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
    Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
    Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of tau positron emission tomography tracer [
    Sander K; Lashley T; Gami P; Gendron T; Lythgoe MF; Rohrer JD; Schott JM; Revesz T; Fox NC; Årstad E
    Alzheimers Dement; 2016 Nov; 12(11):1116-1124. PubMed ID: 26892233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is New in Nuclear Medicine Imaging for Dementia.
    Topçuoğlu ES; Akdemir ÜÖ; Atay LÖ
    Noro Psikiyatr Ars; 2022; 59(Suppl 1):S17-S23. PubMed ID: 36578980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of PET imaging in dementia.
    Iaccarino L; Sala A; Caminiti SP; Perani D
    F1000Res; 2017; 6():1830. PubMed ID: 29071066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving from neurodegenerative dementias, to cognitive proteinopathies, replacing "where" by "what"….
    Allegri RF
    Dement Neuropsychol; 2020; 14(3):237-242. PubMed ID: 32973977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's Dementia: The Emerging Role of Positron Emission Tomography.
    Tripathi SM; Murray AD
    Neuroscientist; 2022 Oct; 28(5):507-519. PubMed ID: 33660556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes.
    Carandini T; Arighi A; Sacchi L; Fumagalli GG; Pietroboni AM; Ghezzi L; Colombi A; Scarioni M; Fenoglio C; De Riz MA; Marotta G; Scarpini E; Galimberti D
    Alzheimers Res Ther; 2019 Oct; 11(1):84. PubMed ID: 31615545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Amyloid PET Imaging Biomarkers for Neurodegeneration: Focus on Tau, Alpha-Synuclein and Neuroinflammation.
    Catafau AM; Bullich S
    Curr Alzheimer Res; 2017; 14(2):169-177. PubMed ID: 27334945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
    Rodriguez-Vieitez E; Nordberg A
    Methods Mol Biol; 2018; 1750():231-251. PubMed ID: 29512077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disclosing tau tangles using PET imaging: a pharmacological review of the radiotracers available in 2021.
    Van Wambeke É; Gérard T; Lhommel R; Hanseeuw B
    Acta Neurol Belg; 2022 Apr; 122(2):263-272. PubMed ID: 34713414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.
    Perani D; Cerami C; Caminiti SP; Santangelo R; Coppi E; Ferrari L; Pinto P; Passerini G; Falini A; Iannaccone S; Cappa SF; Comi G; Gianolli L; Magnani G
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):499-508. PubMed ID: 26341365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Brain Amyloid Imaging.
    Krishnadas N; Villemagne VL; Doré V; Rowe CC
    Semin Nucl Med; 2021 May; 51(3):241-252. PubMed ID: 33482999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging Protein Misfolding in the Brain Using β-Sheet Ligands.
    Harada R; Okamura N; Furumoto S; Yanai K
    Front Neurosci; 2018; 12():585. PubMed ID: 30186106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is tau in the absence of amyloid on the Alzheimer's continuum?: A study of discordant PET positivity.
    Weigand AJ; Bangen KJ; Thomas KR; Delano-Wood L; Gilbert PE; Brickman AM; Bondi MW;
    Brain Commun; 2020; 2(1):fcz046. PubMed ID: 32051933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations Between APOE Variants, Tau and α-Synuclein.
    Rodriguez-Vieitez E; Nielsen HM
    Adv Exp Med Biol; 2019; 1184():177-186. PubMed ID: 32096038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.
    Del Sole A; Malaspina S; Magenta Biasina A
    Funct Neurol; 2016; 31(4):205-215. PubMed ID: 28072381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.